Evonik's Costly Labor Deal Puts Efficiency Drive and Dividends in Focus

Evonik faces pressure on its €400M savings plan from a new wage agreement, testing margins and its revised dividend policy. Investors remain calm ahead of key 2026 results.

A newly ratified wage agreement for Germany's chemical industry has delivered an unwelcome side effect for Evonik. The specialty chemicals group now faces increased pressure on its ambitious cost-saving initiative as it grants staged pay increases to its workforce. These rising personnel expenses threaten to impact both internal efficiency targets and future shareholder returns.

Market Reaction Defies Immediate Concerns

Surprisingly, investors have reacted with notable calm to this complex situation. Evonik's shares closed at €15.45 recently, marking a weekly gain of approximately 11% and trading solidly above its 50-day moving average. This market sentiment suggests confidence that management can offset the higher costs through price adjustments or an accelerated restructuring pace.

The true resilience of Evonik's margins will face an early test. On May 8, 2026, the company will report first-quarter results, providing concrete details on how the new wage costs will be absorbed within its existing annual guidance. That forecast calls for an adjusted EBITDA between €1.7 billion and €2.0 billion.

Efficiency Program "Evonik Tailor Made" Under Scrutiny

The timing of the wage settlement is particularly sensitive for Evonik's leadership in Essen. The group is currently advancing its "Evonik Tailor Made" efficiency program, which targets total savings of €400 million. A significant challenge arises because roughly 80% of these savings are intended to come from cutting up to 2,000 positions in personnel areas.

The higher agreed wages directly counter these savings efforts. Each percentage point increase in labor costs forces the company to seek even stricter cuts elsewhere to achieve its stated net savings goal.

The agreement, finalized on a Wednesday, covers 27 months. It includes a €300 per-head contribution to job security and will raise compensation in two stages: by 2.1% starting in 2027, followed by a further 2.4% increase.

Revised Dividend Policy Faces Headwinds

The rising cost base has direct implications for investors. Evonik has already reduced its dividend for 2025 from €1.17 to €1.00 per share. Furthermore, starting with fiscal year 2026, the company aims to distribute 40% to 60% of its adjusted group profit. Consequently, any net profit diminished by higher wage costs automatically reduces the distributable amount available to shareholders.

This scenario places Evonik's financial strategy in a delicate balancing act, needing to satisfy both employee agreements and investor expectations for returns in the coming years.